Cinnarizine

  • TRADE NAMES: Arlevert; Cerepar; Cinarizins; Cinazyn; Cinnabene; Cinnacet; Cinnageron; Cinnarisine; Cinnipirine; Clinadil; Derozin; Diclamina; Ederal; Libotacin; Medozine; Pericephal; Pervasum; Sepan; Stugeron (Janssen); Surepil; Sureptil; Touristil; Vertizin (Ram)
  • INDICATIONS: Dizziness, tinnitus, nystagmus, nausea and vomiting, motion sickness
  • CLASS: Histamine H1 receptor antagonist, Muscarinic antagonist, Vasodilator, peripheral
  • HALF-LIFE: 4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Barbiturates, Hypnotics, Narcotic analgesics, Sedatives, Tranquilizers, Tricyclic antidepressants

PREGNANCY CATEGORY: C

Our database has 20 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
OCULAR.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top